Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

15.48
Delayed Data
As of Jul 31
 +0.14 / +0.91%
Today’s Change
7.85
Today|||52-Week Range
16.83
+27.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash17.1M21.2M21.3M54.7M
 
 
 
 
 
Short Term Investment Cash2.8M4.4M273.0K33.4M
 
 
 
 
 
Cash & Short Term Investments42.3M35.9M38.2M72.9M
 
 
 
 
 
 
ReceivablesReceivables7.6M4.6M2.1M6.7M
 
 
 
 
 
 
InventoriesInventories263.0K0.000.00683.0K
 
 
 
 
Current AssetsOther Current Assets2.7M1.1M1.7M9.0M
 
 
 
 
 
Current Assets52.9M41.6M42.0M89.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross14.9M14.9M14.4M14.2M
 
 
 
 
 
Depreciation-13.8M-14.3M-14.1M-14.0M
 
 
 
 
 
Other Assets12.9M14.1M3.9M6.3M
 
 
 
 
 
Total Assets82.2M57.4M48.9M136.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.5M4.0M4.2M2.8M
 
 
 
 
 
Short Term Debt0.000.000.0030.0M
 
 
Accrued Expenses12.6M2.0M9.6M15.6M
 
 
 
 
 
Other Current Liabilities23.8M3.4M11.1M22.7M
 
 
 
 
 
Other Liabilities26.3M17.2M15.3M57.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt30.0M30.0M30.0M0.00
 
 
 
 
Other Liabilities4.0M4.7M0.000.00
 
 
 
Total Liabilities67.4M57.9M50.0M61.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity14.8M-454.0K-1.1M75.6M
 
 
 
 
 
Total Shareholder Equity14.8M-454.0K-1.1M75.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding45.7M50.9M59.1M72.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.